A portal to another world – Automated cell engineering in drug discovery
Friday, October 21, 2025
To better suit your schedule and time zone, this webinar will be offered in two separate sessions:
Session 1 broadcasting at 09:00 BST | 10:00 CEST
Session 2 broadcasting at 13:00 EDT | 10:00 PDT
Efficient delivery of biomolecules such as small molecules, proteins, peptides, and intracellular assays remains a critical challenge to both cell engineering and drug discovery across scales. While electroporation is widely used, it has high costs, low cell survival rates, and labor-intensive workflows. Mechanoporation offers a promising alternative, though traditional implementations have struggled to achieve scalability.
Join Dr. Armon Sharei, Portal Bio, and Dennis Condy, Eppendorf, as they discuss how the integration of advanced mechanoporation technology with automated liquid handling enables a cost-effective, high-throughput solution for next-generation cell engineering and drug screening workflows, while also maintaining reproducibility across experiments for greater confidence in results.
Key learning objectives:
- Uncover how mechanoporation opens a whole new galaxy of cargo delivery
- Explore how to leverage automation to go beyond current drug screening and cell engineering workflows
- Discover how to maintain reproducibility whilst boosting your sample throughput
Who should attend?
- Discovery and R&D groups across drug discovery and cell therapy
Certificate of attendance
If you attend the live webinar, you will automatically receive a certificate of attendance, including a learning outcomes summary, for continuing education purposes.
If you view the on-demand webinar, you can request a certificate of attendance by emailing editor@selectscience.net.
Speakers
Dr. Armon Sharei, is the Founder and CEO of Portal Bio, a cell-engineering company headquartered near Boston, MA. Previously, Dr. Sharei founded and served as CEO of SQZ Biotech, where he advanced three oncology clinical trials, established a $1B+ collaboration with Roche, and led the IPO. A Stanford and MIT graduate and former Harvard postdoctoral fellow, Dr. Sharei holds 20+ patents and has been widely recognized for his scientific and entrepreneurial leadership.
Dennis Condy is a Field Applications Specialist with Eppendorf. He graduated with a Bachelor of Science Degree from John Jay College of Criminal Justice and has worked with Eppendorf in different capacities for the past 19 years with the past 7 years as a Field Applications Specialist. In this role he assists in pre- and post-sales support of the epMotion® automated liquid handling systems.
Moderator
